![]() |
Adherence in HIV Disease: How One Person Keeps on Track
|
![]() |
Fast and Easy HIV Testing
|
![]() |
Communicating HIV Treatment Side Effects with Your Doctor
|
![]() |
Making The Decision To Start HIV Therapy
|
![]() |
HIV and Anemia: An Overlooked Danger
|
![]() |
Sticking to It: An HIV Patient Discusses Adherence
|
![]() |
HIV Medicines and Cholesterol: Is There a Link?
|
![]() |
Update on Lipodystrophy in HIV
|
![]() |
Dealing with Wasting in HIV Disease
|
![]() |
One Man Faces the Challenges of Cholesterol and HIV
|
![]() |
HIV and Anemia: One Patient's Story
|
![]() |
Lipodystrophy in HIV Disease
|
![]() |
Why Adherence Matters for Antiretrovirals
|
Late-stage AIDS usually is marked by a sharp decline in the number of CD4+ lymphocytes (a type of white blood cell), followed by a rise in the frequency of opportunistic infections and cancers. Doctors monitor the number and proportion of CD4+ lymphocytes in the patient's blood in order to assess the progression of the disease and the effectiveness of different medications. About 10% of infected individuals never progress to this overt stage of the disease.
OPPORTUNISTIC INFECTIONS. Once the patient's CD4+ lymphocyte count falls below 200 cells/mm3, he or she is at risk for opportunistic infections. The infectious organisms may include:
| ESTIMATED NUMBER OF ADULTS AND CHILDREN LIVING WITH AIDS/HIV WORLDWIDE AS OF 2001 | |
| Regions | Estimate |
| Australia & New Zealand | 15,000 |
| Caribbean | 420,000 |
| East Asia & Pacific | 1,000,000 |
| Eastern Europe & Central Asia | 1,000,000 |
| Latin America | 1,500,000 |
| North Africa & Middle East | 500,000 |
| North America | 950,000 |
| South & Southeast Asia | 5,600,000 |
| Sub-Saharan African | 28,500,000 |
| Western Europe | 550,000 |
| Global total | 40,000,000+ |
AIDS DEMENTIA COMPLEX AND NEUROLOGIC COMPLICATIONS. AIDS dementia complex is a late complication of the disease. It is unclear whether it is caused by the direct effects of the virus on the brain or by intermediate causes. AIDS dementia complex is marked by loss of reasoning ability, loss of memory, inability to concentrate, apathy and loss of initiative, and unsteadiness or weakness in walking. Some patients also develop seizures.
MUSCULOSKELETAL COMPLICATIONS. Patients in late-stage AIDS may develop inflammations of the muscles, particularly in the hip area, and may have arthritis-like pains in the joints.
ORAL SYMPTOMS. Patients may develop a condition called hairy leukoplakia of the tongue. This condition also is regarded by the CDC as an indicator of AIDS. Hairy leukoplakia is a white area of diseased tissue on the tongue that may be flat or slightly raised. It is caused by the Epstein-Barr virus.
AIDS-RELATED CANCERS. Patients with late-stage AIDS may develop Kaposi's sarcoma (KS), a skin tumor that primarily affects homosexual men. KS is the most common AIDS-related malignancy. It is characterized by reddish-purple blotches or patches (brownish in African-Americans) on the skin or in the mouth. About 40% of
The second most common form of cancer in AIDS patients is a tumor of the lymphatic system (lymphoma). AIDS-related lymphomas often affect the central nervous system and develop very aggressively.
Invasive cancer of the cervix is an important diagnostic marker of AIDS in women.
Because HIV infection produces such a wide range of symptoms, the CDC has drawn up a list of 34 conditions regarded as defining AIDS. The physician will use the CDC list to decide whether the patient falls into one of these three groups:
Almost all symptoms of AIDS can occur with other diseases. The general physical examination may range from normal findings to symptoms that are closely associated with AIDS. These symptoms are hairy leukoplakia of the tongue and Kaposi's sarcoma. When the doctor examines the patient, he or she will look for the overall pattern of symptoms rather than any one finding.
|
|
Author Info: Belinda Rowland, Teresa G. Odle, The Gale Group Inc., Gale, Detroit, Gale Encyclopedia of Alternative Medicine, 2005 |